3/15/16 Flashcards
Converted to pyridoxal phosphate and participates as a cofactor in transamination reactions (ALAS cofactor)
- Pyridoxine (Vitamin B6)
- Given with isoniazid
- Succinyl CoA to aminolevulinic acid done by ALAS and its B6 cofactor
Treats: leukemias, Hodgkin and non-Hodgkin’s lymphoma, Wilm’s Tumor, and choriocarcinoma. Can cause NEUROTOXICITY including areflexia (absent reflexes) and peripheral neuritis (tingling in extremities)
- Vincristine (binds tubulin to inhibit microtubule formation)
- Vinca alkaloid
Alkylating agent also known as mustard gas. Used to treat testicular cancer, breast cancer, and lymphomas
Ifosfamide
-Note all alkylating agents can cause myelosuppression
Paclitaxel ADR:
Myelosuppression
HYPERSENSITIVITY (remember skin are also site of stem cells)
During exercise, there is increased sympathetic outflow→vasoconstriction (alpha 1) of splanchnic regions, kidney, skin, and inactive muscles…so why during exercise is there a cumulative DECREASE in TPR?
Selective vasodilation of active musculature is achieved because metabolic factors such as lactate, potassium, and adenosine overcome sympathetic effects in these areas (overall leads to a cumulative decrease in TPR).
Exercise leads to vasodilation in skeletal muscle beds→ decreased TPR. What happens to the following in exercise? CO? Pulmonary resistance? Venous oxygen pressure?
Increased CO (due to increased HR) via sympathetic activity Decreased pulmonary resistance→increased pulmonary flow→better gas exchange Venous oxygen pressure is decreased due to maximum oxygen being unloaded to the tissues
Right sided heart valve pathology…first two things you suspect?
IV drug use or carcinoid tumor
AFP tumor marker
- Gonadal germ cell tumors (yolk sac carcinoma)
- Hepatocellular carcinoma
CA-125 tumor marker
- Monitor the response to treatment and detect recurrence of …
- OVARIAN CANCER
Carbohydrate antigen 19-9 (CA-19-9) tumor marker:
Monitor progress of pancreatic adenocarcinoma
Hunter Syndrome Inheritance
X-linked recessive deficiency in iduronate sulfatase
What is seen in HURLER syndrome (AR) but is absent in Hunter syndrome (XR)? Both are lysosomal storage disorders with accumulation of heparan sulfate and dermatan sulfate (Mucopolysaccharidoses)
-Corneal clouding is absent in Hunter syndrome
Mucopolysaccharidoses Lysosomal Storage Disorder: Hunter Syndrome (X-linked recessive)
Deficiency in iduronate sulfatase→builds up of heparin sulfate and dermatan sulfate
Mild Hurler + aggressive behavior (NO corneal clouding)
Minimal change disease first line treatment
Corticosteroid → Prednisone
Immunosuppressive agent that binds FK-binding protein to inhibit SECRETION of IL-2
Tacrolimus
Immunosuppressive agent that acts as an antagonist to PURINE metabolism (fucks up cell proliferation)
Azathioprine
- MTOR-receptor (mammalian target of rapamycin)
- Binds FK-binding protein→ acts to block SIGNAL transduction of IL-2 receptor
Sirolimus
Warfarin metabolism
CYP450 system (CYP2C9 member) Inducers of CYP450 cause increased metabolism of warfarin
CYP-450 Inducers: Chronic alcoholics Steal phen-phen and Never Refuse Greasy Carbs
- Chronic alcohol use
- St. John’s wort
- Phenytoin
- Phenobarbital
- Nevirapine
- Griseofulvin
- Carbamazepine
Inhibitors of P-450: AAA RACKS IN GQ Magazine
Try this one instead: Crack Amingos GQ
- Acute Alcohol Abuse
- Ritonavir
- Amiodarone
- Cimetidine/ciprofloxacin
- Ketoconazole
- INH (isoniazid)
- Grapefruit juice
- Quinidine
- Macrolides (except azithromycin)
Patients with chronic renal insufficiency are at risk for developing renal osteodystrophy due to decreased conversion of vitamin D from its inactive (25-hydroxyvitamin D) to its active (1,25 dihydrocholecalciferol) forms. How do you treat renal osteodystrophy?
-Calcium, phosphate binders, and calcitriol (synthetic vitamin D3) supplementation
Toxoid vaccine (example diphtheria-tetanus-pertussis vaccination)
- Toxoid = toxin like
- No longer toxic like toxin but maintains some antigenic similarity (share enough epitopes)
- CROSS REACTIVITY of TOXOID via van der Waals forces
Shigella flexneri vaccine is created how?
By linking shigella to an exoprotein A of Pseudomonas aeruginosa as a carrier